Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents-Reference-Cited by-同舟云学术

Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents

Published:2010-10 Issue:10 Volume:34 Page:1395-1397
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Roussou Maria,Kastritis Efstathios,Christoulas Dimitrios,Migkou Magdalini,Gavriatopoulou Maria,Grapsa Irini,Psimenou Erasmia,Gika Dimitra,Terpos Evangelos,Dimopoulos Meletios A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference8 articles.

1. Management of complications in multiple myeloma;Terpos;Semin Hematol,2009

2. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents;Kastritis;Haematologica,2007

3. Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors;Dimopoulos;Clin Lymphoma Myeloma,2009

4. Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study;San-Miguel;Leukemia,2008

5. VMP (bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function and results in reversal of renal impairment: cohort analysis of the phase III VISTA study;Dimopoulos;J Clin Oncol,2009

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low erythropoietin to albumin ratio in the serum predicts less reversibility of renal impairment with poorer prognosis in multiple myeloma;2024-04-09

2. Bendamustine, prednisone and bortezomib (BPV) induction therapy prior autologous stem cell transplantation (ASCT) in 135 newly diagnosed multiple myeloma patients: comparison between patients with normal and impaired renal function;2023-12-11

3. Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management;Cureus;2022-02-25

4. Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients;Journal of Clinical Laboratory Analysis;2020-07-25

5. Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma;Cancer Medicine;2020-04-20